who should not use a glp 1 GLP-1 Meds: What They Really Do and What They Don't GLP-1 Medications: Everything You Need

Dermal fillers for the cheeks can replenish lost volume, resulting in a more defined and uplifted appearance

Its that, with GLP-1s, the user still has a big role to play in their effectiveness

Safety and efficiency of dipeptidyl peptidase IV inhibitors in patients with diabetic kidney disease: A systematic review and meta-analysis

While current data are encouraging, especially regarding cardiovascular benefits and renal protection, continuous research will help elucidate the full spectrum of effects and potential risks over the long term

November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors